The Centers for Disease Control and Prevention on October 8 confirmed that the United States would allow all international visitors who were vaccinated by the WHO or U.S. regulators' authorised COVID-19 vaccines. The US is set to open its borders in November for 33 countries including India, China, and Brazil. The CDC said, ''It'll release additional guidance as the travel requirements are finalized.''
Courtesy: Zee News
WHO authorised the world's first vaccine against any parasitic diseases on October 6, bringing three decades of scientific work to completion. GlaxoSmithKline produced RTS,S (brand name Mosquirix), which substantially decreases the risk of severe illness in malaria-infected children. Since 2019, it has been used as part of a trial study in parts of Africa. India's Bharat Biotech is expected to be the only global vaccine manufacturer by 2029… read-more
Courtesy: The Print
The World Health Organization (WHO) has not yet granted Covaxin emergency use Authorization. It is India's domestically produced coronavirus vaccine. On October 5, the Strategic Advisory Group of Experts on Immunization (SAGE) will have a meeting to discuss the Emergency Use Listing (EUL) for Covaxin. The four-day meeting of the expert group to deliberate on policy recommendations began on October 4. Only six vaccine candidates have been… read-more
Courtesy: Hindustan Times
Bharat Biotech had submitted an EOI (Expression of Interest) seeking emergency use listing (EUL) of Covaxin in April 2021. The World Health Organisation is still in the process of the vaccine assessment and is expected to roll out final results by October. Recently in conversation with the media, the company representative told that the company is closely working with WHO to obtain EUL at the earliest.
Courtesy: The Hindu
After two unsuccessful visits of WHO officials to China, WHO is set to relaunch probe into investigation of the origin of the pandemic. The new team of 20 members ranges experts from scientists, specialists, animal disease experts to geneticists. In absence of a concrete response from China, the new team is likely to face stiff resistance from Chinese authorities. However, after over two years, collecting raw data remains a challenge.
Courtesy: The Free Press Journal
WHO released its first air quality guidelines since 2005 on September 22, with the goal of lowering mortality from key pollutants that cause human deaths. In the guidance to its 194 members, it has reduced the recommended maximum limits for several pollutants. WHO says, "Almost 80% of deaths related to PM2.5 could be avoided in the world if the current air pollution levels were reduced to... updated guideline."
The Delta variant, among all the other three variants of COVID-19, also the variant of concern has been found in more than 180 countries, and the others constitute only a small percentage. WHO Technical Lead, Maria Van Kerkhove said, "Less than one percent each of Alpha, Beta, and Gamma are currently circulating. It's really predominantly Delta around the world." Besides, several viruses spreading because Delta "has become fitter, she added… read-more
Indian Health Minister Mansukh Mandaviya, on September 20, announced that the Government has decided to re-initiate the export of COVID vaccines. Reportedly, WHO Chief Tedros Adhanom Ghebreyesus thanked India and called it an "Important Development" that is crucial for ensuring Vaccine equality across the globe. Earlier, owing to the deadly second wave COVID, India in April 2021, had to stop the shipments of vaccines.
Courtesy: The Hindu
The approval for Emergency Use Authorisation (EUA) of Covaxin, manufactured by Hyderabad-based Bharat Biotech, is now postponed to October 5, by World Health Organization (WHO). WHO's Strategic Advisory Group on Immunization is scheduled to meet on October 5 to grant Covaxin the EUA. A vaccination safety monitoring strategy will be updated on a global, regional, and national level. EUA will be proposed based on Covaxin's trials.
World Health Organisation's (WHO) South-East Asia regional director Dr Poonam Khetrapal Sing on September 13 congratulated India for administrating 75 crore COVID-19 vaccines in a very short time. As India surpassed the 75 crore mark, the achievement was also shared by the Health Ministry. Meanwhile, Sing said, ''while it took 85 days to administer first 100 million doses, India reached 750 million doses from 650 in just 13 days.''
Courtesy: Hindustan Times